Work

Phase II Study of Docetaxel in Combination with Everolimus for Second- or Third-Line Therapy of Advanced Non–Small-Cell Lung Cancer

Year: 2013

Type: article

Study design: Clinical Trial

Source: Journal of Thoracic Oncology

DOI: 10.1097/jto.0b013e318282709c

Authors: Suresh S. Ramalingam, Taofeek K. Owonikoko, Madhusmita Behera, Janakiraman Subramanian, Nabil F. Saba, Scott A. Kono, Anthony A. Gal, Gabriel Sica, R. Donald Harvey, Zhengjia Chen, Carmen M. Klass, Dong M. Shin, Haian Fu, Shi-yong R. Sun, Ramaswamy Govindan, Fadlo R. Khuri

Institutions: Emory University, Winship Cancer Institute, Washington University in St. Louis

Language: English

Topic: Lung Cancer Treatments and Mutations

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

Funders: Georgia Cancer Coalition, National Institutes of Health, National Cancer Institute

Awards: G1832317324, Novel systemic therapy to improve clinical outcome in small cell lung cancer, G973314207

OpenAlex ID: W2013335096

FWCI: 5.594

Cites: 10

Cited by: 39

Related to: 10